|
|
| (One intermediate revision by the same user not shown) |
| Line 17: |
Line 17: |
| **[[3n8x]], [[3n8z]], [[1eqg]], [[5wbe]] - sCOX I + anti-inflammatory drug<br /> | | **[[3n8x]], [[3n8z]], [[1eqg]], [[5wbe]] - sCOX I + anti-inflammatory drug<br /> |
| **[[3n8y]] - sCOX I + aspirin + anti-inflammatory drug<br /> | | **[[3n8y]] - sCOX I + aspirin + anti-inflammatory drug<br /> |
| **[[2oye]], [[2oyu]], [[1ebv]], [[1eqh]], [[1ht5]], [[1ht8]], [[1q4g]], [[5u6x]] - sCOX I + inhibitor<br /> | | **[[2oye]], [[2oyu]], [[1ebv]], [[1eqh]], [[1ht5]], [[1ht8]], [[1q4g]], [[5u6x]], [[7jxt]] - sCOX I + inhibitor<br /> |
| **[[1diy]], [[1fe2]] – sCOX I + arachidonic acid<br /> | | **[[1diy]], [[1fe2]] – sCOX I + arachidonic acid<br /> |
|
| |
|
| Line 43: |
Line 43: |
| **[[6bl3]], [[6bl4]] - mCOX II + indomethacine-dansyl conjugate<br /> | | **[[6bl3]], [[6bl4]] - mCOX II + indomethacine-dansyl conjugate<br /> |
| **[[4o1z]] - sCOX II + anti-inflammatory drug<br /> | | **[[4o1z]] - sCOX II + anti-inflammatory drug<br /> |
| | **[[8et0]] - mCOX II + nanobody<br /> |
|
| |
|
| }} | | }} |
|
| |
|
| [[Category:Topic Page]] | | [[Category:Topic Page]] |
3D Structures of cyclooxygenase3D Structures of cyclooxygenase
Updated on 17-February-2025
{"openlevels":0}
- COX I or prostaglandin H2 synthase I or prostaglandin G/H synthase I
- 6y3c - hCOX I - human
- 3n8v, 1prh - sCOX I – sheep
- 1pth – sCOX I + aspirin
- 1pge, 1pgf, 1pgg - sCOX I + iodinated anti-inflammatory drug
- 1cqe, 3kk6 - sCOX I + anti-inflammatory inhibitor
- 1igx, 1igz - sCOX I + linoleic acid derivative
- 1u67 - sCOX I (mutant) + fatty acid substrate
- 2ayl - sCOX I Mn-substituted + anti-inflammatory drug
- 3n8w - sCOX I (mutant) + anti-inflammatory drug
- 3n8x, 3n8z, 1eqg, 5wbe - sCOX I + anti-inflammatory drug
- 3n8y - sCOX I + aspirin + anti-inflammatory drug
- 2oye, 2oyu, 1ebv, 1eqh, 1ht5, 1ht8, 1q4g, 5u6x, 7jxt - sCOX I + inhibitor
- 1diy, 1fe2 – sCOX I + arachidonic acid
- COX II or prostaglandin H2 synthase II or prostaglandin G/H synthase II
- 5f19 - hCOX II
- 5f1a – hCOX II (mutant) + salicylate
- 5ikq, 5ikr, 5ikt, 5ikv, 5kir - hCOX II + anti-inflammatory drug
- 5cox, 4rrw - mCOX II]] - mouse
- 4rry, 5fdq, 5jvy - mCOX II (mutant)
- 1cx2, 3pgh, 4cox, 6cox - mCOX II + anti-inflammatory inhibitor
- 1pxx, 3ln1, 3q7d, 3rr3, 3nt1, 3ntb, 4m10, 4m11, 4oty, 4ph9, 4rrx, 4z0l - mCOX II + anti-inflammatory drug
- 4rrz, 4rs0, 5jvz, 5jw1 - mCOX II (mutant) + anti-inflammatory drug
- 5w58 - mCOX II + inhibitor
- 3qmo, 4fm5 - mCOX II (mutant) + inhibitor
- 3hs5, 3hs6, 3hs7, 3krk, 3mdl, 3olt, 3olu, 3qh0 - mCOX II (mutant) + fatty acid substrate
- 3ln0, 3mqe, 3ntg - mCOX II + benzopyran inhibitor
- 6v3r – mCOX II + harmaline analog
- 4rut – mCOX II + arachidonic acid
- 6ofy – mCOX II (mutant) + arachidonic acid
- 1cvu – mCOX II + peptide + arachidonic acid
- 1ddx – mCOX II + prostaglandin + arachidonic acid
- 3tzi, 4e1g – mCOX II (mutant) + acrylic acid
- 4otj - mCOX II + anti-tumor drug
- 6bl3, 6bl4 - mCOX II + indomethacine-dansyl conjugate
- 4o1z - sCOX II + anti-inflammatory drug
- 8et0 - mCOX II + nanobody